Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

Conditions:   Clear Cell Renal Cell Carcinoma;   Sarcomatoid Renal Cell Carcinoma;   Stage III Renal Cell Cancer AJCC v8;   Stage IV Renal Cell Cancer AJCC v8 Interventions:   Procedure: Biospecimen Collection;   Procedure: Bone Scan;   Procedure: Computed Tomography;   Biological: Ipilimumab;   Procedure: Magnetic Resonance Imaging;   Drug: Myrciaria dubia Prebiotic Supplement;   Biological: Nivolumab Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials